نتائج البحث

ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.

• Authors : Yang L; Department of Biliary-Pancreatic Surgery, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.; Shanghai Key Laboratory of Biliary Tract Disease, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200011, China.

Subjects: Gemcitabine* ; Gallbladder Neoplasms*/Gallbladder Neoplasms*/Gallbladder Neoplasms*/drug therapy ; Gallbladder Neoplasms*/Gallbladder Neoplasms*/Gallbladder Neoplasms*/genetics

• Source: Cellular oncology (Dordrecht, Netherlands) [Cell Oncol (Dordr)] 2023 Aug; Vol. 46 (4), pp. 1085-1095. Date of Electronic Publication: 2023 Mar 29.Publisher: Springer Country of Publication: Netherlands NLM ID: 101552938 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

In-home Intravesical Chemotherapy for the Treatment of Bladder Cancer, INVITE Trial

• Authors : National Center for Advancing Translational Sciences (NCATS)

• Source: MC240502 In-home INtraVesIcal ThErapy (INVITE) Study - a Phase Ib/II, Single-Arm Trial of Delivering Intravesical Therapy for Bladder Cancer in Patients' Homes

تفاصيل العنوان

A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid Tumors (BOLSTER)

• Source: A Phase 2a, Double-blind, Placebo-controlled, Multi-center, Randomized Study Evaluating LSTA1 When Added to Standard of Care (SoC) Versus Standard of Care Alone in Subjects With Advanced Solid Tumors

تفاصيل العنوان

Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant Chemotherapy in Incidentally Detected Gallbladder Carcinoma After Simple Cholecystectomy or in Front of Radical Resection of BTC (GAIN)

• Authors : German Research Foundation

• Source: Neoadjuvant Chemotherapy With Gemcitabine Plus Cisplatin Followed by Radical Liver Resection Versus Immediate Radical Liver Resection Alone With or Without Adjuvant

تفاصيل العنوان

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

• Authors : National Cancer Institute (NCI)

• Source: A Phase III Randomized Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel Versus Gemcitabine and Cisplatin in Newly Diagnosed, Advanced

تفاصيل العنوان

Comparison of Chemotherapy Before and After Surgery Versus After Surgery Alone for the Treatment of Gallbladder Cancer

• Authors : National Cancer Institute (NCI)

• Source: Optimal Perioperative Therapy for Incidental Gallbladder Cancer (OPT-IN): A Randomized Phase II/III Trial

تفاصيل العنوان

MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005)

• Source: A Multicenter, Open-label, Phase 2 Basket Study of MK-7684A, a Co-formation of Vibostolimab (MK-7684) With Pembrolizumab (MK-3475), With or Without Other Anticancer Therapies in Participants With

تفاصيل العنوان

Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA

• Authors : Shanghai Zhongshan Hospital; Ruijin Hospital; RenJi Hospital ...

• Source: A Multicentre, Open-label, Randomised, Controlled Study of Target Therapy Based on Tumor Molecular Profiling With GEMOX in Recectable Gallbladder Carcinoma Patients

تفاصيل العنوان

Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients with Locally Advanced or Metastatic Gallbladder Cancer

• Authors : Lunxiu Qin, vice president of hospital

• Source: A Phase II Study of Gemcitabine, Cisplatin, Nab-Paclitaxel, and Durvalumab in Locally Advanced or Metastatic Gallbladder Cancer

تفاصيل العنوان

Radiation Therapy in Unresectable Gall Bladder Cancer (RUGB)

• Authors : Shivakumar Gudi, Assistant Professor, Radiation Oncology

• Source: Systemic Therapy With or Without Radiation Therapy in Unresectable Nonmetastatic Gall Bladder Carcinoma: Open Label, Parallel Arm, Phase 2/3 Integrated Randomized Clinical TrialVerma V, Surkar

تفاصيل العنوان